Skip to main content

Bios Equity COF, LP

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Bios Equity COF, LP as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

ACTU Actuate Therapeutics, Inc.

Director, 10% Owner5 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 30, 2025 (view filing)1:03 PM ETJun 273 daysBP Directors, LP and 3 othersDirector, 10% OwnerPPurchase+71.4K$7.00+$500.0K+57.1%196.4K afterDuplicate filing
Jun 30, 2025 (view filing)1:03 PM ETJun 273 daysBP Directors, LP and 3 othersDirector, 10% OwnerPPurchase+71.4K$0.00$0–71.4K afterDerivativeDuplicate filing
Aug 20, 2024 (view filing)8:46 PM ETAug 146 daysBP Directors, LP and 2 othersDirector, 10% OwnerSSale−25.0K$8.00−$200.0K−16.0%131.2K afterAmended3 lotsDuplicate filing
Aug 14, 2024 (view filing)8:54 PM ETAug 14Same dayBP Directors, LP and 2 othersDirector, 10% OwnerPPurchase+500.0K$8.00+$4.00MNew position125.0K after2 lotsDuplicate filing
Aug 14, 2024 (view filing)8:54 PM ETAug 14Same dayBP Directors, LP and 2 othersDirector, 10% OwnerSSale−25.0K$9.00−$225.0K−16.0%131.2K after3 lotsDuplicate filing

INAB IN8BIO, Inc.

10% Owner2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 7, 2025 (view filing)9:48 PM ETMay 25 daysLateBIOS Fund II, LP and 8 others10% OwnerPPurchase+1.15M–––2.43M afterDerivativeDuplicate filing
Oct 11, 2024 (view filing)6:12 PM ETOct 47 daysLateBIOS Fund II, LP and 8 others10% OwnerPPurchase+1.28M–––709.0K afterDerivative2 lots